ENST00000340781.8:c.2410A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000340781.8(SLC26A9):​c.2410A>G​(p.Arg804Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.103 in 1,613,058 control chromosomes in the GnomAD database, including 13,016 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 4034 hom., cov: 32)
Exomes 𝑓: 0.095 ( 8982 hom. )

Consequence

SLC26A9
ENST00000340781.8 missense

Scores

1
1
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.509

Publications

18 publications found
Variant links:
Genes affected
SLC26A9 (HGNC:14469): (solute carrier family 26 member 9) This gene is one member of a family of sulfate/anion transporter genes. Family members are well conserved in their genomic (number and size of exons) and protein (aa length among species) structures yet have markedly different tissue expression patterns. The product of this gene is a highly selective chloride ion channel regulated by WNK kinases. Alternative splicing results in multiple transcript variants encoding differing isoforms.[provided by RefSeq, Dec 2008]
SLC26A9 Gene-Disease associations (from GenCC):
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.041791E-4).
BP6
Variant 1-205915146-T-C is Benign according to our data. Variant chr1-205915146-T-C is described in ClinVar as [Benign]. Clinvar id is 403451.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.403 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC26A9NM_052934.4 linkc.*211A>G 3_prime_UTR_variant Exon 21 of 21 ENST00000367135.8 NP_443166.1 Q7LBE3-1
SLC26A9NM_134325.3 linkc.2410A>G p.Arg804Gly missense_variant Exon 22 of 22 NP_599152.2 Q7LBE3-2B3KXK1
SLC26A9XM_011509121.3 linkc.*211A>G 3_prime_UTR_variant Exon 20 of 20 XP_011507423.1
SLC26A9XM_011509122.3 linkc.*211A>G 3_prime_UTR_variant Exon 18 of 18 XP_011507424.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC26A9ENST00000340781.8 linkc.2410A>G p.Arg804Gly missense_variant Exon 21 of 21 1 ENSP00000341682.4 Q7LBE3-2
SLC26A9ENST00000367135.8 linkc.*211A>G 3_prime_UTR_variant Exon 21 of 21 1 NM_052934.4 ENSP00000356103.3 Q7LBE3-1
SLC26A9ENST00000367134.2 linkc.2410A>G p.Arg804Gly missense_variant Exon 22 of 22 5 ENSP00000356102.2 Q7LBE3-2
SLC26A9ENST00000491127.5 linkn.1971A>G non_coding_transcript_exon_variant Exon 13 of 13 2

Frequencies

GnomAD3 genomes
AF:
0.179
AC:
27221
AN:
151786
Hom.:
4023
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.408
Gnomad AMI
AF:
0.204
Gnomad AMR
AF:
0.121
Gnomad ASJ
AF:
0.113
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0193
Gnomad FIN
AF:
0.103
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.0942
Gnomad OTH
AF:
0.173
GnomAD2 exomes
AF:
0.0995
AC:
24903
AN:
250402
AF XY:
0.0917
show subpopulations
Gnomad AFR exome
AF:
0.417
Gnomad AMR exome
AF:
0.0709
Gnomad ASJ exome
AF:
0.111
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.103
Gnomad NFE exome
AF:
0.0983
Gnomad OTH exome
AF:
0.0981
GnomAD4 exome
AF:
0.0948
AC:
138455
AN:
1461154
Hom.:
8982
Cov.:
32
AF XY:
0.0919
AC XY:
66778
AN XY:
726772
show subpopulations
African (AFR)
AF:
0.427
AC:
14300
AN:
33470
American (AMR)
AF:
0.0751
AC:
3355
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.111
AC:
2900
AN:
26088
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39684
South Asian (SAS)
AF:
0.0209
AC:
1797
AN:
86186
European-Finnish (FIN)
AF:
0.101
AC:
5402
AN:
53402
Middle Eastern (MID)
AF:
0.136
AC:
785
AN:
5762
European-Non Finnish (NFE)
AF:
0.0934
AC:
103787
AN:
1111514
Other (OTH)
AF:
0.101
AC:
6126
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
8029
16057
24086
32114
40143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3834
7668
11502
15336
19170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.180
AC:
27272
AN:
151904
Hom.:
4034
Cov.:
32
AF XY:
0.173
AC XY:
12881
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.408
AC:
16860
AN:
41354
American (AMR)
AF:
0.121
AC:
1852
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.113
AC:
391
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.0191
AC:
92
AN:
4816
European-Finnish (FIN)
AF:
0.103
AC:
1093
AN:
10580
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
292
European-Non Finnish (NFE)
AF:
0.0942
AC:
6402
AN:
67946
Other (OTH)
AF:
0.172
AC:
363
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
996
1991
2987
3982
4978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
262
524
786
1048
1310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.119
Hom.:
6162
Bravo
AF:
0.193
TwinsUK
AF:
0.0903
AC:
335
ALSPAC
AF:
0.0856
AC:
330
ESP6500AA
AF:
0.400
AC:
1764
ESP6500EA
AF:
0.0964
AC:
829
ExAC
AF:
0.105
AC:
12713
Asia WGS
AF:
0.0400
AC:
137
AN:
3478
EpiCase
AF:
0.104
EpiControl
AF:
0.106

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
7.9
DANN
Benign
0.90
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.43
.;T
MetaRNN
Benign
0.00040
T;T
MetaSVM
Benign
-0.98
T
PhyloP100
0.51
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.040
N;N
REVEL
Benign
0.14
Sift
Pathogenic
0.0
D;D
Sift4G
Uncertain
0.055
T;T
Vest4
0.049
MPC
0.18
ClinPred
0.015
T
GERP RS
0.71
gMVP
0.23
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6669481; hg19: chr1-205884274; COSMIC: COSV61604404; API